Payment overview · 2025
General Payments
$115.36
5 reported records · 3 companies
Healthcare provider profile · identity verified
Jack V Diteodoro, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · STAMFORD, CT · NPI 1346338837
Verified facts
What the public records show
CMS Open Payments records show Jack V Diteodoro, M.D. received $115.36 in general payments during 2025 across 5 reported records.
Ardelyx, Inc. accounted for 60.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 344 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $70.21 | 60.9% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $26.79 | 23.2% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $18.36 | 15.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $115.36 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $70.21 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $26.79 | 1 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $18.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 344 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
52 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
344 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2905 | 205 |
| Amlodipine Besylate | Amlodipine Besylate | 1647 | 150 |
| Eliquis | Apixaban | 1619 | 97 |
| Gabapentin | Gabapentin | 1545 | 97 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1410 | 110 |
| Trazodone Hcl | Trazodone Hcl | 1306 | 121 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1282 | 89 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1150 | 76 |
| Mirtazapine | Mirtazapine | 1134 | 104 |
| Losartan Potassium | Losartan Potassium | 1023 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 979 | 85 |
| Furosemide | Furosemide | 866 | 85 |
| Pantoprazole Sodium | Pantoprazole Sodium | 866 | 69 |
| Sertraline Hcl | Sertraline Hcl | 841 | 65 |
| Metformin Hcl | Metformin Hcl | 836 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 810 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 748 | 74 |
| Carvedilol | Carvedilol | 734 | 46 |
| Lisinopril | Lisinopril | 727 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 644 | 26 |
| Levetiracetam | Levetiracetam | 565 | 38 |
| Quetiapine Fumarate | Quetiapine Fumarate | 565 | 38 |
| Spironolactone | Spironolactone | 450 | 28 |
| Donepezil Hcl | Donepezil Hcl | 418 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 387 | 29 |
| Hydralazine Hcl | Hydralazine Hcl | 356 | 18 |
| Divalproex Sodium | Divalproex Sodium | 353 | 36 |
| Januvia | Sitagliptin Phosphate | 349 | 25 |
| Farxiga | Dapagliflozin Propanediol | 344 | 16 |
| Omeprazole | Omeprazole | 336 | 40 |
| Potassium Chloride | Potassium Chloride | 322 | 38 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 320 | 29 |
| Olanzapine | Olanzapine | 306 | 26 |
| Famotidine | Famotidine | 296 | 24 |
| Warfarin Sodium | Warfarin Sodium | 268 | 20 |
| Simvastatin | Simvastatin | 262 | 36 |
| Xarelto | Rivaroxaban | 259 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 234 | suppressed |
| Myrbetriq | Mirabegron | 223 | 13 |
| Memantine Hcl | Memantine Hcl | 221 | 21 |
| Midodrine Hcl | Midodrine Hcl | 218 | 19 |
| Buspirone Hcl | Buspirone Hcl | 215 | 19 |
| Finasteride | Finasteride | 209 | 22 |
| Torsemide | Torsemide | 209 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 207 | 16 |
| Atenolol | Atenolol | 206 | 12 |
| Ezetimibe | Ezetimibe | 202 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 200 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 197 | 22 |
| Jardiance | Empagliflozin | 186 | 12 |
| Montelukast Sodium | Montelukast Sodium | 173 | 12 |
| Baclofen | Baclofen | 165 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 155 | suppressed |
| Allopurinol | Allopurinol | 148 | 15 |
| Lamotrigine | Lamotrigine | 143 | suppressed |
| Risperidone | Risperidone | 138 | 17 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 137 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 137 | 11 |
| Prednisone | Prednisone | 129 | 30 |
| Sucralfate | Sucralfate | 126 | 12 |
| Entresto | Sacubitril/Valsartan | 123 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 122 | suppressed |
| Ketoconazole | Ketoconazole | 120 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 120 | suppressed |
| Glimepiride | Glimepiride | 116 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 116 | 11 |
| Austedo | Deutetrabenazine | 104 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 104 | suppressed |
| Nifedipine Er | Nifedipine | 101 | suppressed |
| Lactulose | Lactulose | 99 | 25 |
| Carbamazepine | Carbamazepine | 95 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 94 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 94 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 91 | 30 |
| Methenamine Hippurate | Methenamine Hippurate | 90 | suppressed |
| Aripiprazole | Aripiprazole | 85 | suppressed |
| Trulicity | Dulaglutide | 83 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 82 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 81 | 17 |
| Mupirocin | Mupirocin | 80 | 28 |
| Chlorthalidone | Chlorthalidone | 79 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 79 | suppressed |
| Latanoprost | Latanoprost | 79 | 19 |
| Alprazolam | Alprazolam | 78 | 19 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 76 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 76 | suppressed |
| Insulin Lispro | Insulin Lispro | 75 | 21 |
| Bupropion Xl | Bupropion Hcl | 72 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 72 | 23 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 72 | suppressed |
| Ozempic | Semaglutide | 69 | 11 |
| Gemtesa | Vibegron | 68 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 67 | suppressed |
| Irbesartan | Irbesartan | 66 | suppressed |
| Lovastatin | Lovastatin | 66 | suppressed |
| Valsartan | Valsartan | 65 | suppressed |
| Trimethoprim | Trimethoprim | 64 | suppressed |
| Bumetanide | Bumetanide | 63 | suppressed |
| Digoxin | Digoxin | 62 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 62 | 45 |
| Methocarbamol | Methocarbamol | 60 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 60 | 24 |
| Zenpep | Lipase/Protease/Amylase | 60 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 59 | 25 |
| Doxazosin Mesylate | Doxazosin Mesylate | 58 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 57 | suppressed |
| Lorazepam | Lorazepam | 57 | 21 |
| Anagrelide Hcl | Anagrelide Hcl | 53 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 53 | 16 |
| Fenofibrate | Fenofibrate,micronized | 53 | suppressed |
| Folic Acid | Folic Acid | 53 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 53 | suppressed |
| Brilinta | Ticagrelor | 52 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 52 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 52 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 51 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 51 | 13 |
| Linzess | Linaclotide | 50 | suppressed |
| Levetiracetam Er | Levetiracetam | 49 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 49 | suppressed |
| Cephalexin | Cephalexin | 48 | 41 |
| Azithromycin | Azithromycin | 46 | 29 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 46 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 25 |
| Alendronate Sodium | Alendronate Sodium | 45 | suppressed |
| Pregabalin | Pregabalin | 45 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 31 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 44 | 30 |
| Benztropine Mesylate | Benztropine Mesylate | 41 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 41 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 41 | suppressed |
| Scopolamine | Scopolamine | 41 | 13 |
| Calcitriol | Calcitriol | 40 | suppressed |
| Clozapine | Clozapine | 40 | suppressed |
| Glipizide | Glipizide | 39 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 39 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Topiramate | Topiramate | 37 | suppressed |
| Budesonide | Budesonide | 36 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 36 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 36 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 36 | suppressed |
| Perphenazine | Perphenazine | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | suppressed |
| Humalog | Insulin Lispro | 35 | 14 |
| Meloxicam | Meloxicam | 35 | 13 |
| Calcium Acetate | Calcium Acetate | 34 | suppressed |
| Xifaxan | Rifaximin | 34 | suppressed |
| Rivastigmine | Rivastigmine | 33 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 32 | 19 |
| Novolog | Insulin Aspart | 31 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 30 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 30 | suppressed |
| Tradjenta | Linagliptin | 30 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Nystatin | Nystatin | 29 | 18 |
| Sodium Chloride | Sodium Chloride 0.45 % | 29 | 20 |
| Gentamicin Sulfate | Gentamicin Sulfate | 28 | 14 |
| Labetalol Hcl | Labetalol Hcl | 28 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 28 | suppressed |
| Timolol Maleate | Timolol Maleate | 28 | suppressed |
| Alphagan P | Brimonidine Tartrate | 27 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 27 | suppressed |
| Pentoxifylline | Pentoxifylline | 27 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 26 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 26 | 17 |
| Enoxaparin Sodium | Enoxaparin Sodium | 26 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Mirabegron Er | Mirabegron | 25 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 25 | suppressed |
| Nyamyc | Nystatin | 24 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 20 |
| Haloperidol | Haloperidol | 23 | suppressed |
| Lidocaine | Lidocaine | 23 | suppressed |
| Metronidazole | Metronidazole | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 22 | 11 |
| Methimazole | Methimazole | 22 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 22 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 20 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 20 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 19 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Ceftazidime | Ceftazidime | 18 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 18 | suppressed |
| Darunavir | Darunavir | 18 | suppressed |
| Dexamethasone | Dexamethasone | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 18 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Tivicay | Dolutegravir Sodium | 18 | suppressed |
| Acyclovir | Acyclovir | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 17 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Glucagon Emergency Kit | Glucagon | 17 | 14 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 17 | suppressed |
| Anastrozole | Anastrozole | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Levemir | Insulin Detemir | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 15 | suppressed |
| Humulin R | Insulin Regular, Human | 15 | suppressed |
| Hydroxyurea | Hydroxyurea | 15 | suppressed |
| Mupirocin | Mupirocin Calcium | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 14 | suppressed |
| Indapamide | Indapamide | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Insulin Aspart | Insulin Aspart | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Motegrity | Prucalopride Succinate | 13 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 13 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Xtampza Er | Oxycodone Myristate | 13 | suppressed |
| Acetic Acid | Acetic Acid | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Bicalutamide | Bicalutamide | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | 12 |
| Nystop | Nystatin | 12 | suppressed |
| Oxacillin Sodium | Oxacillin Sodium | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Isentress | Raltegravir Potassium | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $115.36 · 5 records | Ardelyx, Inc. | Cologuard Collection Kit, FARXIGA, IBSRELA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error